Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
Moritz Bewarder, Gerhard Held, Lorenz Thurner, et al.
Ejhaem
|
February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells
Maximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Annals of Hematology
|
August 8, 2023
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis
Luca Fischer, Linmiao Jiang, Joerg Thomas Bittenbring, et al.
Leukemia & Lymphoma
|
October 20, 2021
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial
Dominic Kaddu-Mulindwa, Vadim Lesan, Christian Berdel, et al.
Hemasphere
|
July 15, 2021
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
Moritz Bewarder, Maximilian Kiefer, Helene Will, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Task2 potassium channels set central respiratory CO2 and O2 sensitivity
Christian Gestreau, Dirk Heitzmann, Joerg Thomas, et al.
The Lancet. Oncology
|
September 23, 2011
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Immunology Letters
|
September 12, 2024
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis
Marie-Christin Hoffmann, Natalie Fadle, Evi Regitz, et al.
European Journal of Immunology
|
March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients
Igor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
Moritz Bewarder, Gerhard Held, Lorenz Thurner, et al.
Ejhaem
|
February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells
Maximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Annals of Hematology
|
August 8, 2023
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis
Luca Fischer, Linmiao Jiang, Joerg Thomas Bittenbring, et al.
Leukemia & Lymphoma
|
October 20, 2021
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial
Dominic Kaddu-Mulindwa, Vadim Lesan, Christian Berdel, et al.
Hemasphere
|
July 15, 2021
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells
Moritz Bewarder, Maximilian Kiefer, Helene Will, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
Task2 potassium channels set central respiratory CO2 and O2 sensitivity
Christian Gestreau, Dirk Heitzmann, Joerg Thomas, et al.
The Lancet. Oncology
|
September 23, 2011
Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Immunology Letters
|
September 12, 2024
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis
Marie-Christin Hoffmann, Natalie Fadle, Evi Regitz, et al.
European Journal of Immunology
|
March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients
Igor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
Page
of 5